Bharat in Betastartup field guide
← All analysis

Source reading · DCVC

Deep tech has to work outside the demonstration.

Computing, energy, factories and biology meet at a practical question: what has to work for the next customer?

This reading follows DCVC’s Deep Tech Opportunities Report 2026, published on 1 July 2026, and its original report PDF. Its companies illustrate an investor’s perspective. They do not establish an unoccupied market or independently verified performance.

Four questions across the report

01

Measure the unit the buyer accepts

A chip benchmark, completed compute job and full shift of materials handling tell different stories. The useful question is which result a customer can accept and pay for, after integration, retries and human intervention. The report connects hardware and software; the investigation still needs a specific workload or physical task.

Next-gen lithographic techniques and smarter chip architectures will help rein in AI’s power requirements. We must invent new forms of efficiency at the data center and cloud levels. Physical AI, embodied in robots, will lower costs across the economy.
02

Treat upkeep as part of the product

The fusion discussion makes maintenance a commercial constraint. Manufacturing and water recovery add another version of that question: what must be serviced, replaced or disposed of to keep producing acceptable output? These are distinct industries, but a first buyer conversation can ask for the complete operating burden rather than the best demonstration result.

There’s room for new ideas about how to make nuclear fusion practical. Industrial production will become more modular and programmable, and therefore cheaper. Wastewater treatment can unlock new supplies of clean water and critical materials.
03

Find the experiment after the prediction

The biology chapters repeatedly return from computation to measurement. A proposed model, candidate or mechanism has to change a research decision that can be tested. An enabling service might organise that handoff, but it should not borrow the source’s therapeutic ambitions as evidence that the service or medicine works.

State-of-the-art computing models and proprietary data generation are opening up new frontiers for TechBio companies. AI-designed molecular glues could turn previously undruggable proteins into targets—and replace many injectable biologics with simple oral drugs. The central challenge for antibody therapies is shifting from discovery to targeting and delivery.
04

Choose a counterparty before copying a category

A country label does not carry the buyer, installed equipment or operating permissions with it. A facility, laboratory or farm offers a more useful starting unit than “India deeptech”. The question is who owns a measured problem and what they currently buy to handle it.

New approaches are unlocking geothermal power in places that were previously thought uneconomic. Big power users are turning to behind-the-meter power capacity and power management. Autonomy and AI are making farms programmable—and helping farmers optimize labor, equipment, and chemical use.

The India lens is an operating comparison

For an Indian reader, the report can supply an investigation question without supplying its answer. Ask a manufacturer about changeovers, a research team about an experiment handoff, or a facility about its actual energy choices. Then compare the present alternative with the proposed change using that organisation’s costs, equipment and purchasing process.

The report’s US power-system examples, large-farm settings and funding conditions stay attached to their original context. This reading makes no claim about local licences, scientific feasibility, clinical benefit or a particular technology’s economics. Those need their own evidence before a project advances.

Read the seven chapters separately

All 26 retained entries are linked below: 24 main opportunities and two named company spotlights. Twenty-two have compact investigation notes. The original titles, summaries, source links and dates are unchanged.

Browse all 26 entries

Where this reading stops

Oklo and Reality Defender remain company spotlights, and the two military-system themes remain source-only. They retain their place in the report without becoming additional product prescriptions. Report forecasts, company milestones and proposed benefits are not treated as achieved results.